Molecular and Cellular Biochemistry

, Volume 406, Issue 1–2, pp 1–7 | Cite as

Investigation of the role of nitric oxide/soluble guanylyl cyclase pathway in ascorbic acid-mediated protection against acute kidney injury in rats

Article
First Online:
Received:
Accepted:

Abstract

The present study investigated the possible involvement of nitric oxide/soluble guanylyl cyclase (NO/sGC) pathway in ascorbic acid (AA)-mediated protection against acute kidney injury (AKI) in rats. The rats were subjected to bilateral renal ischemia by occluding renal pedicles for 40 min followed by reperfusion for 24 h. The AKI was assessed in terms of measuring creatinine clearance (CrCl), blood urea nitrogen (BUN), plasma uric acid, potassium level, fractional excretion of sodium (FeNa), and microproteinuria. The NO level and oxidative stress in renal tissues were assessed by measuring myeloperoxidase activity, thiobarbituric acid reactive substances, superoxide anion generation, and reduced glutathione level. AA (50 and 100 mg/kg, p.o.) was administered for 3 days before subjecting rats to AKI. In separate groups, the nitric oxide synthase inhibitor, L-NAME (20 mg/kg, i.p.) and sGC inhibitor, methylene blue (50 mg/kg, i.p.) was administered prior to AA treatment in rats. The significant decrease in CrCl and increase in BUN, plasma uric acid, potassium, FeNa, microproteinuria, and oxidative stress in renal tissues demonstrated ischemia–reperfusion-induced AKI in rats. The AA treatment ameliorated ischemia–reperfusion-induced AKI along with the increase in renal NO level. The pretreatment with L-NAME and methylene blue abolished protective effect of AA. It is concluded that AA protects against ischemia–reperfusion-induced AKI. Moreover, the NO/sGC pathway finds its definite involvement in AA-mediated reno-protective effect.

Keywords

Ischemia Acute kidney injury Nitric oxide Ascorbic acid 
This is a preview of subscription content, log in to check access.

Notes

Conflict of interest

The authors do not have any conflict of interest.

References

  1. 1.
    James M, Pannu N (2009) Methodological considerations for observational studies of acute kidney injury using existing data sources. J Nephrol 22:295–305PubMedGoogle Scholar
  2. 2.
    Nissenson AR (1998) Acute renal failure: definition and pathogenesis. Kidney Int Suppl 66:7–10Google Scholar
  3. 3.
    Jefayri MK, Grace PA, Mathie RT (2000) Attenuation of reperfusion injury by renal ischemia preconditioning: role of NO. BJU Int 85:1007–1013PubMedCrossRefGoogle Scholar
  4. 4.
    Thadhani R, Pascual M, Bonventre JV (1996) Acute renal failure. N Engl J Med 334:1448–1460PubMedCrossRefGoogle Scholar
  5. 5.
    Weinberg JM, Venkatachalam MA, Roeser NF, Saikumar P, Dong Z, Senter RA, Nissim I (2000) Anaerobic and aerobic pathways for salvage of proximal tubules from hypoxia-induced mitochondrial injury. Am J Physiol Renal Physiol 279:927–943Google Scholar
  6. 6.
    Sekhon CS, Sekhon BK, Singh I, Orak JK, Singh AK (2003) Attenuation of renal ischemia reperfusion injury by triple drug therapy. J Nephrol 16:63–74PubMedGoogle Scholar
  7. 7.
    Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL (2004) Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 43:405–414PubMedCrossRefGoogle Scholar
  8. 8.
    Kapper S, Beck G, Riedel S, Prem K, Haak M, van der Woude FJ, Yard BA (2002) Modulation of chemokine production and expression of adhesion molecules in renal tubular epithelial and endothelial cells by catecholamines. Transplantation 74:253–260PubMedCrossRefGoogle Scholar
  9. 9.
    Korhonen R, Lahti A, Hamalainen M, Kankaanrant H, Moilanen E (2002) Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide. Mol Pharmacol 3:698–704CrossRefGoogle Scholar
  10. 10.
    Chander V, Chopra K (2005) Renal protective effect of molsidomine and l-arginine in ischemia–reperfusion induced injury in rats. J Surg Res 128:132–139PubMedCrossRefGoogle Scholar
  11. 11.
    Hobbs AJ (1997) Soluble guanylate cyclase: an old therapeutic target re-visited. Br J Pharmacol 5:637–640Google Scholar
  12. 12.
    Li Y, Tong X, Maimaitiyiming H, Clemons K, Cao JM, Wang S (2012) Overexpression of cGMP-dependent protein kinase I (PKG-I) attenuates ischemia–reperfusion induced kidney injury. Am J Physiol Renal Physiol 302:561–570CrossRefGoogle Scholar
  13. 13.
    Hosseinzadeh H, Sadeghnia HR, Ziaee T, Danaee A (2005) Protective effect of aqueous saffron extract (Crocus sativus L.) and crocin, its active constituent, on renal ischemia–reperfusion-induced oxidative damage in rats. J Pharm Pharm Sci 8:387–393PubMedGoogle Scholar
  14. 14.
    Valko M, Leifritz D, Moncola J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84PubMedCrossRefGoogle Scholar
  15. 15.
    Sebrel WH, Harris RS (1967) The vitamins: chemistry, physiology, pathology and methods, 2nd edn. Academic press, New YorkGoogle Scholar
  16. 16.
    Wilson JX (2002) The physiological role of dehydroascorbic acid. FEBS Lett 527:5–9PubMedCrossRefGoogle Scholar
  17. 17.
    Korkmaz A, Kolankaya D (2009) The protective effects of ascorbic acid against renal ischemia–reperfusion injury in male rats. Ren Fail 31:36–43PubMedCrossRefGoogle Scholar
  18. 18.
    Buttros JB, Bergamaschi CT, Ribeiro DA, Fracalossi AC, Campos RR (2009) Cardioprotective actions of ascorbic acid during isoproterenol-induced acute myocardial infarction in rats. Pharmacology 84:29–37PubMedCrossRefGoogle Scholar
  19. 19.
    Rana T, Bera AK, Das S, Pan D, Bandopadhyay S, Bhattacharya D, Das SK (2010) Supplementation of ascorbic acid prevents oxidative damage in arsenic loaded hepatic tissue of rat: an ex vivo study. Hum Exp Toxicol 29:965–972PubMedCrossRefGoogle Scholar
  20. 20.
    Gonzalez-Ramirez M, Razo-Juarez LI, Sauer-Ramirez JL, Gonzalez-Trujano ME, Salgado-Ceballos H, Orozco-Suarez S (2010) Anticonvulsive effect of vitamin C on pentylenetetrazol-induced seizures in immature rats. Pharmacol Biochem Behav 97:267–272PubMedCrossRefGoogle Scholar
  21. 21.
    Yan J, Tie G, Messina LM (2012) Tetrahydrobiopterin, l-arginine and vitamin C act synergistically to decrease oxidative stress, increase nitric oxide and improve blood flow after induction of hind limb ischemia in the rat. Mol Med 18:676–684PubMedCentralPubMedGoogle Scholar
  22. 22.
    Green LC, Wagner DA, Joseph G, Skipper PL, Wishnok J, Steven RT (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–138PubMedCrossRefGoogle Scholar
  23. 23.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  24. 24.
    Bradley PP, Priebcat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206–209PubMedCrossRefGoogle Scholar
  25. 25.
    Nichans WG, Samuelson B (1968) Formation of malondialdehyde from phospholipids arachidonate during microsomal lipid peroxidation. Eur J Biochem 6:126–130CrossRefGoogle Scholar
  26. 26.
    Arora S, Kaur T, Kaur A, Singh AP (2014) Glycine aggravates ischemia reperfusion-induced acute kidney injury through N-methyl-d-aspartate receptor activation in rats. Mol Cell Biochem 393:123–131PubMedCrossRefGoogle Scholar
  27. 27.
    Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888PubMedGoogle Scholar
  28. 28.
    Zimmerman BJ, Granger DN (1992) Reperfusion injury. Surg Clin North Am 72:65–83PubMedGoogle Scholar
  29. 29.
    Bonventre JV, Weinberg JM (2003) Recent advances in pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14:2199–2210PubMedCrossRefGoogle Scholar
  30. 30.
    Bredt DS, Snyder SH (1994) Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63:175–195PubMedCrossRefGoogle Scholar
  31. 31.
    Marletta MA, Rusche KM, Spiering MM (1998) Reactions catalyzed by tetrahydrobiopterin-free nitric oxide synthase. Biochemistry 44:15503–15512Google Scholar
  32. 32.
    Alderton WK, Cooper CE, Knowles RG (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 1:593–615CrossRefGoogle Scholar
  33. 33.
    Ignarro LJ (2002) Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol 53:503–514PubMedGoogle Scholar
  34. 34.
    Yamashita H, Akamine S, Sumida Y, Inoue M, Sawada T, Nagayasu T, Oka T (2004) Inhaled nitric oxide attenuates apoptosis in ischemia–reperfusion injury of the rabbit lung. Ann Thorac Surg 78:292–297PubMedCrossRefGoogle Scholar
  35. 35.
    Trifilieff A, Fujitani Y, Mentz F, Dugas B, Fuentes M, Bertrand C (2000) Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression. J Immunol 165:1526–1533PubMedCrossRefGoogle Scholar
  36. 36.
    Schutte H, Witzenrath M, Mayer K, Weissmann N, Schell A, Rosseau S, Seeger W, Grimminger F (2000) The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs. Am J Physiol Lung Cell Mol Physiol 279:496–502Google Scholar
  37. 37.
    Beavo JA, Brunton LL (2002) Cyclic nucleotide research-still expanding after half a century. Nat Rev Mol Cell Biol 3:710–718PubMedCrossRefGoogle Scholar
  38. 38.
    Pilz RB, Casteel DE (2003) Regulation of gene expression by cyclic GMP. Circ Res 93:1034–1046PubMedCrossRefGoogle Scholar
  39. 39.
    Higa OH, Parra ER, Ab’Saber AM, Farhat C, Higa R, Capelozzi VL (2007) Protective effects of ascorbic acid pretreatment in a rat model of intestinal ischemia reperfusion injury: a histomorphometric study. Clinics (Sao Paulo) 62:315–320CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of Pharmaceutical SciencesGuru Nanak Dev UniversityAmritsarIndia

Personalised recommendations